Machine Learning Applications in Multiple Sclerosis Diagnosis

Machine learning techniques are transforming the early detection and characterisation of multiple sclerosis (MS) by leveraging large datasets of clinical assessments and magnetic resonance imaging (MRI). Supervised algorithms such as support vector machines (SVMs) and random forests have shown promise in classifying patients according to disease state, while deep learning architectures, notably convolutional neural networks (CNNs), excel in automated lesion detection and segmentation. Unsupervised learning approaches enable the discovery of novel subtypes by grouping patients with similar radiomic signatures, refining prognostic stratification. Advanced models also integrate multimodal data—from clinical scores and cerebrospinal fluid markers to structural connectomes—to predict both conversion from clinically isolated syndrome and long-term disability trajectories. Interpretability methods improve transparency by highlighting image regions that drive model decisions, supporting clinical adoption. Together, these advances promise enhanced diagnostic accuracy, personalised risk profiling and more timely therapeutic intervention.

Research from Nature Portfolio

Recent studies have applied unsupervised machine learning to large MRI datasets to redefine MS phenotypes based on early pathological features. By clustering thousands of scans, researchers have identified cortex-led, white matter-led and lesion-led subtypes that correlate with distinct progression risks and treatment responses. In parallel, exploration of supervised frameworks has yielded predictive models for conversion to secondary-progressive MS and long-term disability. These frameworks incorporate demographic, imaging and clinical variables to deliver robust predictions of disease course years before clinical milestones, offering a data-driven basis for personalised treatment planning.

Machine Learning Applications in Multiple Sclerosis Diagnosis publication trend

The graph below shows the total number of articles in machine learning applications in multiple sclerosis diagnosis across all publications each year (not limited to Nature Index journals).

Technical terms

Machine learning: Algorithmic methods that enable computers to learn patterns from data and improve performance over time.

Unsupervised learning: Techniques that identify structure in unlabelled data by grouping similar examples without predefined categories.

Convolutional neural network (CNN): A deep learning architecture optimised for analysing image data via layered convolution and pooling operations.

Support vector machine (SVM): A supervised algorithm that classifies data by finding the hyperplane that maximises separation between classes.

Radiomic features: Quantitative descriptors extracted from medical images to characterise tissue heterogeneity and pathology.

Connectome: A comprehensive map of neural connections in the brain used to model network-level interactions.

Hodgkin-Huxley model: A mathematical framework describing ion channel dynamics in neurons, often adapted to simulate demyelination effects.

References

1. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis. The Lancet Regional Health - Europe (2024).
2. Modeling and simulation for prediction of multiple sclerosis progression. Computers in Biology and Medicine (2024).
3. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nature Communications (2021).
4. Multiple Sclerosis Identification by 14-Layer Convolutional Neural Network With Batch Normalization, Dropout, and Stochastic Pooling. Frontiers in Neuroscience (2018).
5. Uncovering convolutional neural network decisions for diagnosing multiple sclerosis on conventional MRI using layer-wise relevance propagation. NeuroImage Clinical (2019).
6. Multiple Sclerosis Diagnosis Using Machine Learning and Deep Learning: Challenges and Opportunities. Sensors (2022).
7. Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study. npj Digital Medicine (2020).